Effects of continuous-flow left ventricular assist devices on cerebral hemodynamics

被引:6
|
作者
Karahan, Mehmet [1 ]
Kocabeyoglu, Sinan Sabit [1 ]
Kervan, Umit [1 ]
Sert, Dogan Emre [1 ]
Aygun, Emre [1 ]
Tola, Muharrem [2 ]
Demirkan, Burcu [3 ]
Mungan, Semra [4 ]
Kursun, Oguzhan [4 ]
Catav, Zeki [1 ]
Pac, Mustafa [1 ]
机构
[1] Turkiye Yuksek Ihtisas Hosp, Cardiovasc Surg, Kizilay St 4 Altindag, TR-06100 Ankara, Turkey
[2] Turkiye Yuksek Ihtisas Hosp, Radiol, Ankara, Turkey
[3] Turkiye Yuksek Ihtisas Hosp, Cardiol, Ankara, Turkey
[4] Ankara Numune Hosp, Neurol, Ankara, Turkey
关键词
carotid artery; middle cerebral artery; pulsatility index; resistive index; ventricular assist device; ADVANCED HEART-FAILURE; BLOOD-FLOW; CAROTID CIRCULATION; RESISTIVE INDEX; ISCHEMIC-STROKE; VELOCITY; AUTOREGULATION; RESISTANCE; ARTERIES;
D O I
10.1111/aor.13616
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Continuous-flow left ventricular assist devices (LVADs) reduce peak systolic flow, increase diastolic flow, and eliminate pulsatility of circulation. Altered blood flow may lead to a change in end-organ perfusion. Analysis of the flow dynamics of the arteries of end organs, such as the brain, may indicate whether an organ is perfused sufficiently. The aim of this study is to evaluate and identify the flow pattern changes of carotid (CA) and middle cerebral arteries (MCA) in LVAD patients and to compare with heart failure patients and healthy volunteers. Eighty-nine individuals were included in this cross-sectional study. Participants were divided into three groups: LVAD patients (n = 31), heart failure patients (n = 26), and healthy volunteers (n = 27). Carotid and transcranial Doppler ultrasonography were performed for all study groups for peak systolic velocity (PSV), end-diastolic velocity (EDV), pulsatility (PI), and resistive (RI) indices of CA and MCA. Flow dynamics were compared between the groups. Doppler ultrasonographic data were analyzed at a median 12 (3-47) months after LVAD implantation. CA-PSV was lower in LVAD group compared with the other two groups (P < .001), MCA-PSV of LVAD and heart failure groups were similar and lower than healthy volunteers (P < .05). The highest values for CA-EDV were found in the LVAD group (P < .05). MCA-EDV values were found to be lowest in heart failure group (P < .05). For PI and RI, in all CA and MCA, the LVAD group had lower indices compared with the other two groups (P < .001). In addition, MCA flow analysis in patients with LVADs was identified for the first time with this study.
引用
收藏
页码:457 / 464
页数:8
相关论文
共 50 条
  • [41] Factor Xa inhibitors in patients with continuous-flow left ventricular assist devices
    Parikh, Vishal Y.
    Parikh, Umang M.
    Moctezuma-Ramirez, Angel
    Lamba, Harveen K.
    George, Joggy K.
    Fedson, Savitri
    Nair, Ajith P.
    Frazier, O. H.
    Delgado, Reynolds M.
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2020, 68 (11) : 1278 - 1284
  • [42] Defining a Decade of Experience with Continuous-Flow Left Ventricular Assist Devices Preface
    Shah, Palak
    Cowger, Jennifer A.
    CARDIOLOGY CLINICS, 2018, 36 (04) : XIII - XIII
  • [43] Cerebrovascular events in children on intracorporeal continuous-flow left ventricular assist devices
    Sert, Dogan Emre
    Kocabeyoglu, Sinan Sabit
    Kervan, Umit
    Karahan, Mehmet
    Beyazal, Osman Fehmi
    Akdi, Mustafa
    Yilmaz, Abdulkadir
    Catav, Zeki
    ARTIFICIAL ORGANS, 2020, 44 (12) : 1251 - 1258
  • [44] Hemodynamic and exercise performance with Pulsatile and continuous-flow left ventricular assist devices
    Haft, Jonathan
    Armstrong, William
    Dyke, David B.
    Aaronson, Keith D.
    Koelling, Todd M.
    Farrar, David J.
    Pagani, Francis D.
    CIRCULATION, 2007, 116 (11) : I8 - I15
  • [45] Metabolic Dysfunction in Continuous-Flow Left Ventricular Assist Devices Patients and Outcomes
    Nguyen, Ann B.
    Imamura, Teruhiko
    Besser, Stephanie
    Rodgers, Daniel
    Chung, Ben
    Raikhelkar, Jayant
    Kalantari, Sara
    Smith, Bryan
    Sarswat, Nitasha
    LaBuhn, Colleen
    Jeevanandam, Valluvan
    Kim, Gene
    Sayer, Gabriel
    Uriel, Nir
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (22):
  • [46] Intravenous Iron Repletion in Patients With Continuous-Flow Left Ventricular Assist Devices
    Bernier, Thomas D.
    Stern, Gretchen
    Buckley, Leo F.
    Vieira, Jefferson L.
    Siddiqi, Hasan K.
    Mehra, Mandeep R.
    ASAIO JOURNAL, 2023, 69 (03) : E115 - E117
  • [47] Benefits of Neurohormonal Therapy in Patients With Continuous-Flow Left Ventricular Assist Devices
    Yousefzai, Rayan
    Brambatti, Michela
    Tran, Hao A.
    Pedersen, Rachel
    Braun, Oscar O.
    Baykaner, Tina
    Ghashghaei, Roxana
    Sulemanjee, Nasir Z.
    Cheema, Omar M.
    Rappelt, Matthew
    Baeza, Carmela
    Alkhayyat, Abdulaziz
    Shi, Yang
    Pretorius, Victor
    Greenberg, Barry
    Adler, Eric
    Thohan, Vinay
    ASAIO JOURNAL, 2020, 66 (04) : 409 - 414
  • [48] The Physiological Rationale for Incorporating Pulsatility in Continuous-Flow Left Ventricular Assist Devices
    Grosman-Rimon, Liza
    Billia, Filio
    Kobulnik, Jeremy
    Bar-Ziv, Stacey Pollock
    Cherney, David Z.
    Rao, Vivek
    CARDIOLOGY IN REVIEW, 2018, 26 (06) : 294 - 301
  • [49] Concomitant mitral repair and continuous-flow left ventricular assist devices: Is it warranted?
    Fukuhara, Shinichi
    Takeda, Koji
    Chiuzan, Codruta
    Han, Jiho
    Kurlansky, Paul A.
    Takayama, Hiroo
    Naka, Yoshifumi
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 154 (04): : 1303 - +
  • [50] Measuring Blood Pressure in Patients with Continuous-Flow Left Ventricular Assist Devices
    Kerk, K. L.
    Truong, T. H.
    Lim, C. H.
    Tan, T. E.
    Sim, D.
    Lim, C. P.
    Sivathasan, C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S340 - S340